BioSpace News Archive

Axonics ® Launches ARTISTRY Study to Collect and Analyze Real-World Data of Patients Implanted with the Axonics r-SNM System ARTISTRY will enroll up to 300 patients across 30 centers in North America and include patients across all four clinical indications for Axonics Therapy

Combination of automation and technology-enabled services supports more cost-effective workflows and expanded distribution models

Nascent Biotech, Inc. is pleased to announce that the Company has received initial In-Vitro study results from its collaboration with Syracuse University showing that Pritumumab successfully blocked viral entry into cells.

Varian (NYSE: VAR) congratulates the United States Trade Representative and the Ministry of Development, Industry and Foreign Trade of Brazil on achieving the first steps of a trade agreement focused on good regulatory practices, trade facilitation, and anti-corruption. Varian’s Chief Executive Officer, Dow Wilson, serves as t

AstraZeneca’s TAGRISSO ® (osimertinib) has received acceptance for its supplemental New Drug Application (sNDA) and has also been granted Priority Review in the US for the adjuvant treatment of patients with early-stage (IB, II and IIIA) epidermal growth factor receptor-mutated

Horizon Therapeutics plc Announces TEPEZZA ® (teprotumumab-trbw) Selected as a Winner of the Chicago Innovation Award

Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies in oncology and neuroscience, announced today the presentation of new preclinical data on its VISTA antagonist antibodies at the American Association for Cancer Research (AACR) Virtual Special Conference on Tumor Immunology and Immunot

Transparency Market Research has published a new report titled, Surgical Drapes Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

The demand for renal disease treatment products and therapies has been incrementing steadily in the past few years, owing to the prevalence of poor kidney functions among a vast population base across the world, especially in the Asia Pacific region, and increased government support.

Regarded as one of the most efficient and preferred drug delivery techniques in the medical sector, the global parenteral drugs market may incur expansive growth during the forecast period of 2019-2029.